External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

ITSOS 2024

September 27 - September 28

New York, USA

itsos.org

We will be contributing to topics related to

Oncology

Add to calendar

Agenda

Medical Materials

02:45 PM

Duration 15mins New York, USA

LCMC3: Impact of Circulating Tumor DNA Status, Pathologic Regression, Resection Status and Adjuvant Treatment on Survival in NSCLC

Jay Lee, Neil Keil, Yan Tang, David Carbone, Jamie Chaft, Mark Kris, Bruce Johnson, Ignacio Wistuba, Paul Bunn, Jay Lee, David Kwiatkowski, Valerie Rusch, Toloza, Eric, Raz, Dan, D'Souza, Desmond, Finley, David, Downey, Robert, Katja Schulze, Ann Johnson, Evelise Brandao, Alan Nicholas, Jessica Grindheim

Oncology | Lung Cancer

Notify me

Add to calendar

06:00 PM

Duration 15mins New York, USA

Five-Year Follow-Up of IMpower010: Exploratory Analysis of Outcomes and Safety by Extent of Resection in Stage II-IIIA Non-Small Cell Lung Cancer (NSCLC) With Adjuvant Atezolizumab

Nasser Altorki, Enriqueta Felip, Olexandr Golobordko, Alex Martinez-Marti, Caicun Zhou, Achim Rittmeyer, Antonio Chella, Martin Reck, Tibor Csoszi, Hirotsugu Kenmotsu, Yuh-Min Chen, Jian Fang, Rüdiger Liersch, Beiying Ding, Leonardo Crama, Marcus Ballinger, Elizabeth Bennett, Barbara Gitlitz, Heather Wakelee

Oncology | Lung Cancer

Notify me

Add to calendar

Coming soon

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.